Business description: Abbott Laboratories

Abbott Laboratories specializes in the research, development, manufacturing and marketing of pharmaceutical and medical products. Net sales break down by family of products as follows:

- diagnostic systems and instruments (39.1%);

- vascular devices (24.7%): endoprosthetic systems, dilation catheters, arterial closures, etc.;

- nutrition products (12.1%): pediatric nutrition products, nutritional supplements, and dietetic products;

- medicine (8.2%): anesthetics, antiviral products, antibiotics, inhibitors, anti-inflammatories, etc.;

- other (15.9%).

Net sales are distributed geographically as follows: the United States (38.5%), Germany (5.8%), China (5.6%), India (4.4%), Switzerland (4.1%), Japan (3.8%), Netherlands (2.7%) and others (35.1%).

Number of employees: 114,000

Sales by Activity: Abbott Laboratories

Fiscal Period: December20202021202220232024

Medical Devices

11.79B 14.37B 14.69B 16.89B 18.99B

Diagnostics

10.8B 15.64B 16.58B 9.99B 9.34B

Nutrition

7.65B 8.29B 7.46B 8.15B 8.41B

Established Pharmaceutical

4.3B 4.72B 4.91B 5.07B 5.19B

Other

66M 52M 11M 14M 16M
See all business segments

Geographical breakdown of sales: Abbott Laboratories

Fiscal Period: December20202021202220232024

United States

13.02B 16.64B 18.14B 15.45B 16.32B

All Other Countries

12.58B 15.52B 14.84B 14.08B 14.85B

Germany

2.11B 2.57B 2.34B 2.34B 2.54B

China

1.96B 2.39B 2.13B 2.25B 2.11B

India

1.32B 1.56B 1.65B 1.75B 1.82B

Switzerland

1.14B 1.31B 1.34B 1.64B 1.75B

Japan

1.39B 1.7B 1.93B 1.51B 1.44B

The Netherlands

1.08B - - 1.07B 1.12B

Canada

- 1.38B 1.28B - -
See all geographic segments

Executive Committee: Abbott Laboratories

Manager TitleAgeSince
Chief Executive Officer 51 2020-03-30
Director of Finance/CFO 52 2023-08-31
Chief Investment Officer 50 -
Chief Tech/Sci/R&D Officer - 2020-02-29
Sales & Marketing - -
See ABBOTT LABORATORIES governance

Composition of the Board of Directors: Abbott Laboratories

Director TitleAgeSince
Director/Board Member 74 2008-10-09
Director/Board Member 63 2011-12-08
Director/Board Member 66 2011-12-08
Director/Board Member 70 2017-02-15
Director/Board Member 64 2017-06-28
Chairman 51 2021-12-09
Director/Board Member 57 2018-06-07
Director/Board Member 64 2019-09-08
Director/Board Member 65 2021-04-22
Director/Board Member 53 2021-08-29
Composition of the Board of Directors

Shareholders: Abbott Laboratories

NameEquities%Valuation
Vanguard Fiduciary Trust Co.
9.792 %
169,823,136 9.792 % 23 098 M $
BlackRock Advisors LLC
6.058 %
105,058,274 6.058 % 14 289 M $
4.478 %
77,664,753 4.478 % 10 563 M $
Capital Research & Management Co. (International Investors)
3.853 %
66,824,002 3.853 % 9 089 M $
Capital Research & Management Co. (Global Investors)
2.925 %
50,734,446 2.925 % 6 900 M $
NameEquities%Valuation
BRAM - Bradesco Asset Management SA DTVM
0.000185 %
38,528 0.000185 % 430 328 $
List of ABBOTT LABORATORIES shareholders

Holdings: Abbott Laboratories

NameEquities%Valuation
15,934,048 74.99% 6,621,371,498 $
76,259,451 77.9% 260,052,354 $
17,949,800 51.69% 42,743,320 $
2,061,855 4.74% 2,230,515 $

Company details: Abbott Laboratories

Abbott Laboratories

100 Abbott Park Road

60064-6400, Abbott Park

+224 667 6100

http://www.abbott.com
address Abbott Laboratories(ABT)

Group companies: Abbott Laboratories

NameCategory and Sector
Biotechnology
Pharmaceuticals: Major
Medical Specialties
Financial Conglomerates
Abbott AG
Medical Specialties
See all subsidiaries

Other Medical Equipment, Supplies & Distribution

Change 5d. change 1-year change 3-years change Capi.($)
-0.35%-0.99%+30.64%+21.94% 232B
+0.15%+0.50%+15.40%-0.26% 113B
+0.06%+2.46%+34.16%+111.11% 57.77B
+0.21%-1.20%-20.91%-28.13% 50.05B
+1.09%+3.45%-11.96%+41.19% 39.78B
+0.99%+1.18%-23.70%+7.83% 32.84B
+0.92%-4.67%-9.45%+19.05% 24.69B
-0.50%-2.29%+27.64%-41.63% 22.94B
-0.77%-3.07%+8.16%+10.45% 22.88B
+0.29%-1.23%+52.64%+29.06% 20.87B
Average +0.20%-1.13%+10.26%+17.06% 61.73B
Weighted average by Cap. +0.03%-0.88%+16.55%+19.97%
See all sector performances
  1. Stock Market
  2. Equities
  3. ABT Stock
  4. Company Abbott Laboratories